Stereotactic ablative body radiotherapy improves overall survival compared with conventional fully fractured radiotherapy in non-small cell lung cancer

Stereotactic ablative body radiotherapy was associated with improved overall survival and superior freedom from local failure compared with conventional fully fractionated radiotherapy among patients with inoperable stage I non–small cell lung cancer, according to results presented at the International Association for the Study of Lung Cancer 18th Annual World Conference on Lung Cancer in Japan.
Cancer Therapy Advisor